A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma

NCT00998322 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

BIOLOGICAL: REOLYSIN
DRUG: Gemcitabine

Sponsor

Oncolytics Biotech

Collaborators

[object Object]